Permanent pacing for complete atrioventricular block after nonsurgical (alcohol) septal reduction in patients with obstructive hypertrophic cardiomyopathy

被引：29

作者：

Reinhard, W

Ten Cate, FJ

Scholten, M

de Laat, LE

Vos, J

机构：

[1] Thorax Ctr Rotterdam, Erasmus MC, Dept Cardiol, NL-3015 GD Rotterdam, Netherlands

[2] Univ Regensburg, Klin & Poliklin Innere Med 2, D-8400 Regensburg, Germany

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 93卷 / 08期

关键词：

D O I：

10.1016/j.amjcard.2003.12.065

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Nonsurgical septal reduction is a newly developed, catheter-based therapeutic option for patients with drug-refractory obstructive hypertrophic cardiomyopathy. A circumscribed septal infarction is generated to reduce the left ventricular outflow tract gradient. The spontaneous regression of complete atrioventricular block after the procedure and the main complication of the intervention are examined, and treatment with permanent pacing is evaluated. (C) 2004 by Excerpta Medica, Inc.

引用

收藏

页码：1064 / 1066

页数：3

相关论文

共 12 条

[1] Complete heart block: Determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy [J].

Chang, SM ;

Nagueh, SF ;

Spencer, WH ;

Lakkis, NM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (02) :296-300

[2] Transcoronary Ablation of Septal Hypertrophy (TASH) in HOCM: a five year experience [J].

Kuhn, H .

ZEITSCHRIFT FUR KARDIOLOGIE, 2000, 89 (06) :559-564

[3] Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: One-year follow-up [J].

Lakkis, NM ;

Nagueh, SF ;

Dunn, JK ;

Killip, D ;

Spencer, WH .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :852-855

[4] Hypertrophic cardiomyopathy - A systematic review [J].

Maron, BJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (10) :1308-1320

[5] HYPERTROPHIC CARDIOMYOPATHY - INTERRELATIONS OF CLINICAL MANIFESTATIONS, PATHOPHYSIOLOGY, AND THERAPY .2. [J].

MARON, BJ ;

BONOW, RO ;

CANNON, RO ;

LEON, MB ;

EPSTEIN, SE .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (14) :844-852

[6] OPERATIVE TREATMENT IN HYPERTROPHIC SUBAORTIC STENOSIS - TECHNIQUES, AND RESULTS OF PREOPERATIVE AND POSTOPERATIVE ASSESSMENTS IN 83 PATIENTS [J].

MORROW, AG ;

REITZ, BA ;

EPSTEIN, SE ;

HENRY, WL ;

CONKLE, DM ;

ITSCOITZ, SB ;

REDWOOD, DR .

CIRCULATION, 1975, 52 (01) :88-102

[7] Pharmacological therapy for hypertrophic cardiomyopathy:: what is the evidence for success? [J].

Rydén, L ;

Gadler, F .

EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0L) :L21-L25

[8] RECOMMENDATIONS REGARDING QUANTITATION IN M-MODE ECHOCARDIOGRAPHY - RESULTS OF A SURVEY OF ECHOCARDIOGRAPHIC MEASUREMENTS [J].

SAHN, DJ ;

DEMARIA, A ;

KISSLO, J ;

WEYMAN, A .

CIRCULATION, 1978, 58 (06) :1072-1083

[9] Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients [J].

Seggewiss, H ;

Gleichmann, U ;

Faber, L ;

Fassbender, D ;

Schmidt, HK ;

Strick, S .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :252-258

[10] NONSURGICAL MYOCARDIAL REDUCTION FOR HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY [J].

SIGWART, U .

LANCET, 1995, 346 (8969) :211-214